London: In a ray of hope for children with relapsed leukaemia, scientists claim that a new treatment has been found to improve survival rates dramatically.A research, funded by Cancer Research UK and Leukaemia & Lymphoma Research, has found that a new drug, Mitoxantran, can increase three-year survival rates to almost 70 per cent, `The Daily Telegraph` reported.
"This is the first time that a trial in ALL has been stopped so early after one drug had such clear benefits for patients." PTI
FM Arun Jaitley presents budget in Parliament
Budget 2014-15: IT exemption limit raised to Rs 2.5 lakh
The history of Indian Budget
Marrow Donor Registry of India launches Gujarat chapter